NYSE:HQH · New York Stock Exchange
+$0.15 today
Vol 0.28M · Avg 0.14M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Abrdn Healthcare Investors earnings power becomes long-term shareholder value. Use this page to compare HQH returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
9.0%
avg 4.7%
ROIC
9.0%
avg 0.5%
ROA
9.0%
avg 4.7%
Analysis
ROE is currently the strongest return metric at 9.0% versus its period average of 4.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Frank T. Gentile | Senior Vice President of Research and Portfolio Manager | — | — | 64 | $0.00 | <0.01% |
Daniel R. Omstead | Portfolio Manager | — | — | 73 | $178,268.56 | 0.31% |
Christopher F. Brinzey | Senior Vice President of Research and Portfolio Manager | — | — | — | $0.00 | <0.01% |
Jason C. Akus | Vice President of Research and Portfolio Manager | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -14.0% | N/A — |
| Revenue | N/A | N/A | +16.1% | N/A — |
| Net Income | N/A | N/A | -10.4% | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Recent growth has been strongest in Revenue at +16.1% over three years.
Competitors
Peer companies in the same sector
Trinity Capital Inc.
NASDAQ:TRIN
$1.33B
Virtus Investment Partners, Inc.
NASDAQ:VRTS
$1.01B
Kayne Anderson BDC, Inc.
NYSE:KBDC
$901.70M
MidCap Financial Investment Corporation
NASDAQ:MFIC
$822.08M
Bain Capital Specialty Finance, Inc.
NYSE:BCSF
$819.94M
Carlyle Secured Lending, Inc.
NASDAQ:CGBD
$756.82M
PennantPark Floating Rate Capital Ltd.
NYSE:PFLT
$742.15M
New Mountain Finance Corporation
NASDAQ:NMFC
$675.33M
Horizon Technology Finance Corporation
NASDAQ:HRZN
$208.29M
Who manages HQH?
Abrdn Healthcare Investors (HQH) lists 4 active executives. The top listed executive is Frank T. Gentile, Senior Vice President of Research and Portfolio Manager.
Are HQH insiders buying or selling?
Recent insider activity shows net buying of $894,425.37.
Explore More
Continue the stock analysis
Jump to another research area for this company.